Business Description
Vaxil Bio Ltd
NAICS : 325412
SIC : 3741
ISIN : CA92243L1076
Description
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.4 | |||||
| 3-Year FCF Growth Rate | 30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 41.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.36 | |||||
| Quick Ratio | 11.36 | |||||
| Cash Ratio | 11.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.67 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -3.95 | |||||
| EV-to-EBITDA | -3.95 | |||||
| EV-to-FCF | -2.06 | |||||
| Price-to-Net-Current-Asset-Value | 1 | |||||
| Price-to-Net-Cash | 1 | |||||
| Earnings Yield (Greenblatt) % | -25.32 | |||||
| FCF Yield % | -15.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxil Bio Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.008 | ||
| Beta | -0.12 | ||
| Volatility % | 164.22 | ||
| 14-Day RSI | 41.18 | ||
| 14-Day ATR (C$) | 0.000007 | ||
| 20-Day SMA (C$) | 0.01 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.005 - 0.035 | ||
| Shares Outstanding (Mil) | 136.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxil Bio Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxil Bio Ltd Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaxil Bio Ltd Frequently Asked Questions
What is Vaxil Bio Ltd(TSXV:VXL)'s stock price today?
The current price of TSXV:VXL is C$0.01. The 52 week high of TSXV:VXL is C$0.04 and 52 week low is C$0.01.
When is next earnings date of Vaxil Bio Ltd(TSXV:VXL)?
The next earnings date of Vaxil Bio Ltd(TSXV:VXL) is .
Does Vaxil Bio Ltd(TSXV:VXL) pay dividends? If so, how much?
Vaxil Bio Ltd(TSXV:VXL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers